Celularity Inc (CELU) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US1511902041
Celularity Inc financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 26.55 m USD |
| Gross profit | 6.48 m USD |
| Operating income | -61.31 m USD |
| EBIT | -91.71 m USD |
| Net income | -91.72 m USD |
| Diluted EPS – continuing operations | -3.59 USD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Celularity Inc
Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn's disease. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn's) and degenerative disease; and PDA-002 for treating multiple sclerosis, rheumatoid arthritis, stroke, and diabetic peripheral neuropathy. The company also produces, sells, and licenses products used in surgical and wound care markets, such as Biovance, Biovance 3L, Rebound, Interfyl, and Centaflex; and collects, processes, and stores umbilical cord and placental blood and tissue after full-term pregnancies under the LifebankUSA brand. Celularity Inc. has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products; and research collaboration services agreement with Regeneron Pharmaceuticals, Inc. to support the research of allogeneic cell therapy candidates. Celularity Inc. was founded in 1998 and is headquartered in Florham Park, New Jersey.
More stocks
- MEXCO ENERGY CORP (MXC)
- Alset Inc. (AEI)
- Borealis Foods Inc. (BRLS)
- Mercer Bancorp, Inc. (MSBB)
- IGC Pharma, Inc. (IGC)
- BetterLife Pharma Inc. (BETRF)
- AWARE INC /MA/ (AWRE)
- HEALTHY EXTRACTS INC. (HYEX)
- Presurance Holdings, Inc. (PRHI)
- Lument Finance Trust, Inc. (LFT)
- BuzzFeed, Inc. (BZFD)
- Western Uranium & Vanadium Corp. (WSTRF)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.